Cervical dystonia: clinical and therapeutic features in 85 patients Distonia cervical: aspectos clínicos e terapêuticos de 85 pacientes

We studied patients with cervical dystonia (CD) to determine clinical features and response to botulinum toxin A (BoNT/A). Patients were submitted to clinical, laboratory and neuroimaging evaluation. BoNT/A was injected locally in 81 patients using electromyographic guidance. Four patients who had h...

Full description

Saved in:
Bibliographic Details
Main Authors: Carlos Henrique F. Camargo, Hélio A.G. Teive, Nilson Becker, Maria Helena Herdoíza Baran, Rosana Hermínia Scola, Lineu César Werneck
Format: Article
Language:English
Published: Thieme Revinter Publicações 2008-03-01
Series:Arquivos de Neuro-Psiquiatria
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2008000100005
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849684431057453056
author Carlos Henrique F. Camargo
Hélio A.G. Teive
Nilson Becker
Maria Helena Herdoíza Baran
Rosana Hermínia Scola
Lineu César Werneck
author_facet Carlos Henrique F. Camargo
Hélio A.G. Teive
Nilson Becker
Maria Helena Herdoíza Baran
Rosana Hermínia Scola
Lineu César Werneck
author_sort Carlos Henrique F. Camargo
collection DOAJ
description We studied patients with cervical dystonia (CD) to determine clinical features and response to botulinum toxin A (BoNT/A). Patients were submitted to clinical, laboratory and neuroimaging evaluation. BoNT/A was injected locally in 81 patients using electromyographic guidance. Four patients who had had previous treatment were considered to be in remission. The average ages at onset of focal dystonia and segmental dystonia were greater than for generalized dystonia (p<0.0003). The severity of the abnormal head-neck movements were more severe among the patients with generalized dystonia (p<0.001). Pain in the cervical area was noted in 59 patients. It was not possible to determine the etiology of the disease in 62.3% of patients. Tardive dystonia was the most common secondary etiology. A major improvement in the motor symptoms of CD and pain was observed in patients following treatment with BoNT/A. The tardive dystonia subgroup did not respond to the treatment. Dysphagia was observed in 2.35% of the patients.<br>Para identificar os aspectos clínicos e a resposta a toxina botulínica A (TxBA), pacientes com distonia cervical (DC) foram submetidos a avaliação clínica, laboratorial e neuroimagem. O tratamento com TxBA foi aplicado a 81 pacientes guiado por eletroneuromiografia. Quatro pacientes, com tratamento prévio, foram considerados em remissão. A média de idade de início dos sintomas de pacientes com distonia focal e segmentar foi maior que a encontrada em pacientes com distonia generalizada (p<0,0003). A gravidade das alterações motoras cervicais foi maior entre os pacientes com distonia generalizada que nos pacientes com distonia focal (p<0,001). Graus diferentes de dor na região cervical foram relatados por 59 dos pacientes. Não foi possível determinar a etiologia da doença em 62,3% dos pacientes sendo distonia tardia a mais comum. Houve acentuada melhora dos sintomas motores e da dor da DC com a aplicação de TxBA. O subgrupo de pacientes com distonia tardia não respondeu ao tratamento. Disfagia ocorreu em 2,35% dos pacientes.
format Article
id doaj-art-bb2aa5f0a1e04447800f153e88045445
institution DOAJ
issn 0004-282X
1678-4227
language English
publishDate 2008-03-01
publisher Thieme Revinter Publicações
record_format Article
series Arquivos de Neuro-Psiquiatria
spelling doaj-art-bb2aa5f0a1e04447800f153e880454452025-08-20T03:23:27ZengThieme Revinter PublicaçõesArquivos de Neuro-Psiquiatria0004-282X1678-42272008-03-01661152110.1590/S0004-282X2008000100005Cervical dystonia: clinical and therapeutic features in 85 patients Distonia cervical: aspectos clínicos e terapêuticos de 85 pacientesCarlos Henrique F. CamargoHélio A.G. TeiveNilson BeckerMaria Helena Herdoíza BaranRosana Hermínia ScolaLineu César WerneckWe studied patients with cervical dystonia (CD) to determine clinical features and response to botulinum toxin A (BoNT/A). Patients were submitted to clinical, laboratory and neuroimaging evaluation. BoNT/A was injected locally in 81 patients using electromyographic guidance. Four patients who had had previous treatment were considered to be in remission. The average ages at onset of focal dystonia and segmental dystonia were greater than for generalized dystonia (p<0.0003). The severity of the abnormal head-neck movements were more severe among the patients with generalized dystonia (p<0.001). Pain in the cervical area was noted in 59 patients. It was not possible to determine the etiology of the disease in 62.3% of patients. Tardive dystonia was the most common secondary etiology. A major improvement in the motor symptoms of CD and pain was observed in patients following treatment with BoNT/A. The tardive dystonia subgroup did not respond to the treatment. Dysphagia was observed in 2.35% of the patients.<br>Para identificar os aspectos clínicos e a resposta a toxina botulínica A (TxBA), pacientes com distonia cervical (DC) foram submetidos a avaliação clínica, laboratorial e neuroimagem. O tratamento com TxBA foi aplicado a 81 pacientes guiado por eletroneuromiografia. Quatro pacientes, com tratamento prévio, foram considerados em remissão. A média de idade de início dos sintomas de pacientes com distonia focal e segmentar foi maior que a encontrada em pacientes com distonia generalizada (p<0,0003). A gravidade das alterações motoras cervicais foi maior entre os pacientes com distonia generalizada que nos pacientes com distonia focal (p<0,001). Graus diferentes de dor na região cervical foram relatados por 59 dos pacientes. Não foi possível determinar a etiologia da doença em 62,3% dos pacientes sendo distonia tardia a mais comum. Houve acentuada melhora dos sintomas motores e da dor da DC com a aplicação de TxBA. O subgrupo de pacientes com distonia tardia não respondeu ao tratamento. Disfagia ocorreu em 2,35% dos pacientes.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2008000100005distoniadistonia cervicaltoxina botulínicadisfagiadystoniacervical dystoniabotulinum toxindysphagia
spellingShingle Carlos Henrique F. Camargo
Hélio A.G. Teive
Nilson Becker
Maria Helena Herdoíza Baran
Rosana Hermínia Scola
Lineu César Werneck
Cervical dystonia: clinical and therapeutic features in 85 patients Distonia cervical: aspectos clínicos e terapêuticos de 85 pacientes
Arquivos de Neuro-Psiquiatria
distonia
distonia cervical
toxina botulínica
disfagia
dystonia
cervical dystonia
botulinum toxin
dysphagia
title Cervical dystonia: clinical and therapeutic features in 85 patients Distonia cervical: aspectos clínicos e terapêuticos de 85 pacientes
title_full Cervical dystonia: clinical and therapeutic features in 85 patients Distonia cervical: aspectos clínicos e terapêuticos de 85 pacientes
title_fullStr Cervical dystonia: clinical and therapeutic features in 85 patients Distonia cervical: aspectos clínicos e terapêuticos de 85 pacientes
title_full_unstemmed Cervical dystonia: clinical and therapeutic features in 85 patients Distonia cervical: aspectos clínicos e terapêuticos de 85 pacientes
title_short Cervical dystonia: clinical and therapeutic features in 85 patients Distonia cervical: aspectos clínicos e terapêuticos de 85 pacientes
title_sort cervical dystonia clinical and therapeutic features in 85 patients distonia cervical aspectos clinicos e terapeuticos de 85 pacientes
topic distonia
distonia cervical
toxina botulínica
disfagia
dystonia
cervical dystonia
botulinum toxin
dysphagia
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2008000100005
work_keys_str_mv AT carloshenriquefcamargo cervicaldystoniaclinicalandtherapeuticfeaturesin85patientsdistoniacervicalaspectosclinicoseterapeuticosde85pacientes
AT helioagteive cervicaldystoniaclinicalandtherapeuticfeaturesin85patientsdistoniacervicalaspectosclinicoseterapeuticosde85pacientes
AT nilsonbecker cervicaldystoniaclinicalandtherapeuticfeaturesin85patientsdistoniacervicalaspectosclinicoseterapeuticosde85pacientes
AT mariahelenaherdoizabaran cervicaldystoniaclinicalandtherapeuticfeaturesin85patientsdistoniacervicalaspectosclinicoseterapeuticosde85pacientes
AT rosanaherminiascola cervicaldystoniaclinicalandtherapeuticfeaturesin85patientsdistoniacervicalaspectosclinicoseterapeuticosde85pacientes
AT lineucesarwerneck cervicaldystoniaclinicalandtherapeuticfeaturesin85patientsdistoniacervicalaspectosclinicoseterapeuticosde85pacientes